{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:15:53Z","timestamp":1792790153044,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020912","name":"King Faisal University","doi-asserted-by":"publisher","award":["KFU252866"],"award-info":[{"award-number":["KFU252866"]}],"id":[{"id":"10.13039\/501100020912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Guidelines recommend routine urine albumin-to-creatinine ratio (uACR) screening in patients with diabetes (annual) and hypertension (at least once, with follow-up annually if CKD is found). However, real-world adherence remains uncertain and appears suboptimal. This study aimed to quantify the global prevalence of albuminuria testing in high-risk adults with hypertension and\/or diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of observational studies reporting the proportion of adults with diabetes mellitus, hypertension, or both who underwent albuminuria testing in routine care. Multiple databases were searched through Web of Science, PubMed, Google Scholar, and Scopus. Pooled uACR testing prevalence was calculated using random-effects meta-analysis of proportions, with heterogeneity assessed by Cochran\u2019s Q and I\u00b2 statistics. Subgroup analyses examined differences by patient group, test modality, and country income level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty studies (from diverse countries and settings) met the inclusion criteria, involving over 29\u00a0million patients. Albuminuria testing rates were low in most settings. Overall, only about one in five high-risk patients underwent a uACR test in routine clinical practice. Pooled uACR testing prevalence was approximately 22% (fixed-effect model dominated by a large U.S. dataset), and 49% (95% CI: 7\u201393%) in a random-effects model accounting for extreme between-study variability (I\u00b2 ~100%). Testing uptake ranged from &lt;\u20095% in some systems to nearly 100% in protocolized programs. Subgroup comparisons showed higher rates in diabetes-focused and screening-driven studies, whereas hypertension cohorts had particularly low uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>uACR testing remains underutilized among patients with hypertension or diabetes. This gap between guidelines and practice leads to delayed CKD detection and timely initiation of appropriate treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04672-5","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T15:06:54Z","timestamp":1764860814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Underutilization of albuminuria screening in adults with diabetes mellitus or hypertension: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Mohamed A.","family":"Albekery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim S.","family":"Alhomoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama S.","family":"Alabdulathim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah A.","family":"Almajed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad A.","family":"Alobaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar K.","family":"Alomair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukainah A.","family":"Al Shehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"10075","key":"4672_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5.","journal-title":"Lancet"},{"issue":"4","key":"4672_CR2","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"9731","key":"4672_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"Association of estimated glomerular filtration rate","year":"2010","unstructured":"Association of estimated glomerular filtration rate. And albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5.","journal-title":"Lancet"},{"key":"4672_CR4","unstructured":"United States Renal Data System. 2024 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2024."},{"issue":"7","key":"4672_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385. https:\/\/doi.org\/10.1038\/s41581-024-00820-6.","journal-title":"Nat Rev Nephrol"},{"issue":"10225","key":"4672_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","journal-title":"Lancet"},{"issue":"12","key":"4672_CR7","first-page":"776","volume":"96","author":"DY Gaitonde","year":"2017","unstructured":"Gaitonde DY, Cook DL, Rivera IM. Chronic kidney disease: detection and evaluation. Am Fam Physician. 2017;96(12):776\u201383.","journal-title":"Am Fam Physician"},{"key":"4672_CR8","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2025. Diabetes Care. 2025;48(Supplement_1):S59-S85. https:\/\/doi.org\/10.2337\/dc25-S004.","DOI":"10.2337\/dc25-S004"},{"issue":"12","key":"4672_CR9","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: A consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO). Diabetes Care. 2022;45(12):3075\u201390. https:\/\/doi.org\/10.2337\/dci22-0027.","journal-title":"Diabetes Care"},{"key":"4672_CR10","unstructured":"Writing Committee Members*, Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC et al. \/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American college of cardiology\/American Heart association joint committee on clinical practice guidelines. Hypertens Dallas Tex 1979. 2025;82(10):e212\u2013316."},{"issue":"38","key":"4672_CR11","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"issue":"4","key":"4672_CR12","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","volume":"78","author":"JI Shin","year":"2021","unstructured":"Shin JI, Chang AR, Grams ME, et al. Albuminuria testing in hypertension and diabetes: an Individual-Participant data Meta-Analysis in a global consortium. Hypertension. 2021;78(4):1042\u201352. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17323.","journal-title":"Hypertension"},{"issue":"7","key":"4672_CR13","doi-asserted-by":"publisher","first-page":"e2326230","DOI":"10.1001\/jamanetworkopen.2023.26230","volume":"6","author":"CD Chu","year":"2023","unstructured":"Chu CD, Xia F, Du Y, et al. Estimated prevalence and testing for albuminuria in US adults at risk for chronic kidney disease. JAMA Netw Open. 2023;6(7):e2326230. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26230.","journal-title":"JAMA Netw Open"},{"key":"4672_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"3","key":"4672_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147\u201353. https:\/\/doi.org\/10.1097\/XEB.0000000000000054.","journal-title":"Int J Evid Based Healthc"},{"issue":"9","key":"4672_CR16","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2337\/dc21-0723","volume":"44","author":"D Alfego","year":"2021","unstructured":"Alfego D, Ennis J, Gillespie B, et al. Chronic kidney disease testing among At-Risk adults in the U.S. Remains low: Real-World evidence from a National laboratory database. Diabetes Care. 2021;44(9):2025\u201332. https:\/\/doi.org\/10.2337\/dc21-0723.","journal-title":"Diabetes Care"},{"key":"4672_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/951734","volume":"2012","author":"I Codreanu","year":"2012","unstructured":"Codreanu I, Sali V, Gaibu S, et al. Prevalence of hypertension and diabetes and coexistence of chronic kidney disease and cardiovascular risk in the population of the Republic of Moldova. Int J Hypertens. 2012;2012:1\u20138. https:\/\/doi.org\/10.1155\/2012\/951734.","journal-title":"Int J Hypertens"},{"issue":"3","key":"4672_CR18","first-page":"30","volume":"66","author":"SC Dash","year":"2018","unstructured":"Dash SC, Agarwal SK, Panigrahi A, Mishra J, Dash D. Diabetes, hypertension and kidney disease combination DHKD syndrome is common in India. J Assoc Physicians India. 2018;66(3):30\u20133.","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"4672_CR19","doi-asserted-by":"publisher","first-page":"e019778","DOI":"10.1136\/bmjopen-2017-019778","volume":"8","author":"D Flood","year":"2018","unstructured":"Flood D, Garcia P, Douglas K, Hawkins J, Rohloff P. Screening for chronic kidney disease in a community-based diabetes cohort in rural guatemala: a cross-sectional study. BMJ Open. 2018;8(1):e019778. https:\/\/doi.org\/10.1136\/bmjopen-2017-019778.","journal-title":"BMJ Open"},{"issue":"4","key":"4672_CR20","first-page":"307","volume":"4","author":"A Ghafari","year":"2010","unstructured":"Ghafari A, Ahmadnezhad E, Sepehrvand N, et al. Screening for asymptomatic kidney disease in high-risk population of Urmia, Iran. Iran J Kidney Dis. 2010;4(4):307\u201311.","journal-title":"Iran J Kidney Dis"},{"issue":"3","key":"4672_CR21","first-page":"253","volume":"37","author":"RM Guthrie","year":"1993","unstructured":"Guthrie RM, Lott JA. Screening for proteinuria in patients with hypertension or diabetes mellitus. J Fam Pract. 1993;37(3):253\u20136.","journal-title":"J Fam Pract"},{"issue":"4","key":"4672_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.37757\/MR2010.V12.N4.5","volume":"12","author":"R Herrera","year":"2010","unstructured":"Herrera R, Almaguer M, Chipi J, et al. Albuminuria as a marker of kidney and cardio-cerebral vascular damage. Isle of youth study (ISYS), Cuba. MEDICC Rev. 2010;12(4):20\u20136. https:\/\/doi.org\/10.37757\/MR2010.V12.N4.5.","journal-title":"MEDICC Rev"},{"issue":"3","key":"4672_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/jhh.2014.62","volume":"29","author":"R Major","year":"2015","unstructured":"Major R, Davies M, Crasto W, Gray L, Webb D, Khunti K. Association between undiagnosed hypertension and microalbuminuria in South Asians without known diabetes. J Hum Hypertens. 2015;29(3):185\u20139. https:\/\/doi.org\/10.1038\/jhh.2014.62.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"4672_CR24","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1053\/j.ajkd.2007.12.017","volume":"51","author":"PA McCullough","year":"2008","unstructured":"McCullough PA, Li S, Jurkovitz CT, et al. CKD and cardiovascular disease in screened High-Risk volunteer and general populations: the kidney early evaluation program (KEEP) and National health and nutrition examination survey (NHANES) 1999\u20132004. Am J Kidney Dis. 2008;51(4):S38\u201345. https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.017.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4672_CR25","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1093\/ndt\/14.9.2150","volume":"14","author":"L Kissmeyer","year":"1999","unstructured":"Kissmeyer L, Kong C, Cohen J, Unwin RJ, Woolfson RG, Neild GH. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 1999;14(9):2150\u20135. https:\/\/doi.org\/10.1093\/ndt\/14.9.2150.","journal-title":"Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"3","key":"4672_CR26","first-page":"411","volume":"19","author":"B Hitha","year":"2008","unstructured":"Hitha B, Pappachan JM, Pillai HB, et al. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience. Saudi J Kidney Dis Transpl Off Publ Saudi Cent Organ Transpl Saudi Arab. 2008;19(3):411\u20139.","journal-title":"Saudi J Kidney Dis Transpl Off Publ Saudi Cent Organ Transpl Saudi Arab"},{"issue":"9","key":"4672_CR27","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2337\/dc20-2715","volume":"44","author":"N Stempniewicz","year":"2021","unstructured":"Stempniewicz N, Vassalotti JA, Cuddeback JK, et al. Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. Health care organizations. Diabetes Care. 2021;44(9):2000\u20139. https:\/\/doi.org\/10.2337\/dc20-2715.","journal-title":"Diabetes Care"},{"issue":"6861","key":"4672_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/bmj.305.6861.1051","volume":"305","author":"CM Forsblom","year":"1992","unstructured":"Forsblom CM, Groop PH, Ekstrand A, Groop LC. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ. 1992;305(6861):1051\u20133. https:\/\/doi.org\/10.1136\/bmj.305.6861.1051.","journal-title":"BMJ"},{"issue":"3","key":"4672_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000158526","volume":"29","author":"E Kr\u00f3l","year":"2009","unstructured":"Kr\u00f3l E, Rutkowski B, Czarniak P, et al. Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol. 2009;29(3):264\u201373. https:\/\/doi.org\/10.1159\/000158526.","journal-title":"Am J Nephrol"},{"key":"4672_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.13181\/mji.v18i2.352","volume":"1","author":"S Soegondo","year":"2009","unstructured":"Soegondo S, Prodjosudjadi W, Setiawati A. Prevalence and risk factors for microalbuminuria in a cross-sectional study of type-2 diabetic patients in indonesia: a subset of DEMAND study. Med J Indones Published Online May. 2009;1:124. https:\/\/doi.org\/10.13181\/mji.v18i2.352.","journal-title":"Med J Indones Published Online May"},{"issue":"581","key":"4672_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3399\/bjgp10X544041","volume":"60","author":"V Van Der Meer","year":"2010","unstructured":"Van Der Meer V, Wielders HPM, Grootendorst DC, et al. Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Br J Gen Pract. 2010;60(581):884\u201390. https:\/\/doi.org\/10.3399\/bjgp10X544041.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"4672_CR32","first-page":"1055","volume":"22","author":"Z Gouda","year":"2011","unstructured":"Gouda Z, Mashaal G, Bello AK, et al. Egypt Information, Prevention, and treatment of chronic kidney disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt. Saudi J Kidney Dis Transpl Off Publ Saudi Cent Organ Transpl Saudi Arab. 2011;22(5):1055\u201363.","journal-title":"Saudi J Kidney Dis Transpl Off Publ Saudi Cent Organ Transpl Saudi Arab"},{"issue":"1","key":"4672_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jcma.2011.01.001","volume":"74","author":"SC Chiang","year":"2011","unstructured":"Chiang SC, Lee JK, Chen CH, et al. Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach\u2013a DEMAND II study. J Chin Med Assoc JCMA. 2011;74(1):3\u201310. https:\/\/doi.org\/10.1016\/j.jcma.2011.01.001.","journal-title":"J Chin Med Assoc JCMA"},{"issue":"10","key":"4672_CR34","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3109\/0886022X.2011.615969","volume":"33","author":"V Le\u017eai\u0107","year":"2011","unstructured":"Le\u017eai\u0107 V, Dimkovi\u0107 N, Pekovi\u0107 GP, et al. Screening of a population at risk of chronic kidney disease: analysis of factors associated with low eGFR and microalbuminuria. Ren Fail. 2011;33(10):969\u201376. https:\/\/doi.org\/10.3109\/0886022X.2011.615969.","journal-title":"Ren Fail"},{"issue":"8","key":"4672_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/nep.12112","volume":"18","author":"LM Ong","year":"2013","unstructured":"Ong LM, Punithavathi N, Thurairatnam D, et al. Prevalence and risk factors for proteinuria: T he N ational K Idney F oundation of M Alaysia L Ifecheck H ealth S Creening programme. Nephrology. 2013;18(8):569\u201375. https:\/\/doi.org\/10.1111\/nep.12112.","journal-title":"Nephrology"},{"issue":"11","key":"4672_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/jhh.2015.120","volume":"30","author":"J Pol\u00f3nia","year":"2016","unstructured":"Pol\u00f3nia J, Carvalho D, Nazar\u00e9 J, et al. Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with\/without diabetes in Portugal. J Hum Hypertens. 2016;30(11):726\u201330. https:\/\/doi.org\/10.1038\/jhh.2015.120.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"4672_CR37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3904\/kjim.2014.243","volume":"31","author":"YU Kang","year":"2016","unstructured":"Kang YU, Bae EH, Ma SK, Kim SW. Determinants and burden of chronic kidney disease in a high-risk population in korea: results from a cross-sectional study. Korean J Intern Med. 2016;31(5):920\u20139. https:\/\/doi.org\/10.3904\/kjim.2014.243.","journal-title":"Korean J Intern Med"},{"issue":"6","key":"4672_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000495082","volume":"48","author":"NR Burrows","year":"2018","unstructured":"Burrows NR, Vassalotti JA, Saydah SH, et al. Identifying High-Risk individuals for chronic kidney disease: results of the CHERISH community demonstration project. Am J Nephrol. 2018;48(6):447\u201355. https:\/\/doi.org\/10.1159\/000495082.","journal-title":"Am J Nephrol"},{"issue":"1","key":"4672_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000500706","volume":"50","author":"J Lee","year":"2019","unstructured":"Lee J, Chu C, Guzman D, et al. Albuminuria testing by race and ethnicity among patients with hypertension with and without diabetes. Am J Nephrol. 2019;50(1):48\u201354. https:\/\/doi.org\/10.1159\/000500706.","journal-title":"Am J Nephrol"},{"issue":"3","key":"4672_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000455389","volume":"45","author":"LL Wong","year":"2017","unstructured":"Wong LL, Kalantar-Zadeh K, Page V, Hayashida G, You AS, Rhee CM. Insights from screening a Racially and ethnically diverse population for chronic kidney disease. Am J Nephrol. 2017;45(3):200\u20138. https:\/\/doi.org\/10.1159\/000455389.","journal-title":"Am J Nephrol"},{"issue":"1","key":"4672_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12882-020-1705-3","volume":"21","author":"FCF Otieno","year":"2020","unstructured":"Otieno FCF, Ogola EN, Kimando MW, Mutai K. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a County hospital clinic in kenya: implications to care and need for screening. BMC Nephrol. 2020;21(1):73. https:\/\/doi.org\/10.1186\/s12882-020-1705-3.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4672_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.diabres.2007.10.024","volume":"80","author":"MC Thomas","year":"2008","unstructured":"Thomas MC. The assessment and management of albuminuria in primary care. Diabetes Res Clin Pract. 2008;80(1):83\u20138. https:\/\/doi.org\/10.1016\/j.diabres.2007.10.024.","journal-title":"Diabetes Res Clin Pract"},{"key":"4672_CR43","unstructured":"Microalbuminuria en pacientes. Adultos ambulatorios sin Control nefrol\u00f3gico y Con factores de Riesgo de Enfermedad renal cr\u00f3nica En servicios de Nefrolog\u00eda de Per\u00fa. Nefrolog\u00eda. 2012;3210.3265\/Nefrologia.pre2011.Nov.10865."},{"key":"4672_CR44","doi-asserted-by":"publisher","first-page":"103185","DOI":"10.1016\/j.eclinm.2025.103185","volume":"82","author":"D Van Mil","year":"2025","unstructured":"Van Mil D, Kieneker LM, Harms E, et al. Effectiveness of a systematic home-based albuminuria screening programme to detect chronic kidney disease in high-risk individuals in primary care (SALINE): a cross-sectional screening study. eClinicalMedicine. 2025;82:103185. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103185.","journal-title":"eClinicalMedicine"},{"issue":"Supplement1","key":"4672_CR45","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.2337\/dc25-S004","volume":"48","author":"NA ElSayed","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed NA, McCoy RG, et al. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in Diabetes\u20142025. Diabetes Care. 2025;48(Supplement1):S59\u201385. https:\/\/doi.org\/10.2337\/dc25-S004.","journal-title":"Diabetes Care"},{"issue":"6","key":"4672_CR46","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","volume":"40","author":"N Tangri","year":"2023","unstructured":"Tangri N, Peach EJ, Franz\u00e9n S, Barone S, Kushner PR. Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: the REVEAL-CKD study. Adv Ther. 2023;40(6):2869\u201385. https:\/\/doi.org\/10.1007\/s12325-023-02482-5.","journal-title":"Adv Ther"},{"issue":"9","key":"4672_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11906-023-01248-2","volume":"25","author":"S Cutrell","year":"2023","unstructured":"Cutrell S, Alhomoud IS, Mehta A, Talasaz AH, Van Tassell B, Dixon DL. ACE-Inhibitors in hypertension: A historical perspective and current insights. Curr Hypertens Rep. 2023;25(9):243\u201350. https:\/\/doi.org\/10.1007\/s11906-023-01248-2.","journal-title":"Curr Hypertens Rep"},{"key":"4672_CR48","doi-asserted-by":"publisher","first-page":"1580645","DOI":"10.3389\/fmed.2025.1580645","volume":"12","author":"IS Alhomoud","year":"2025","unstructured":"Alhomoud IS, Albekery MA, Alqadi R, et al. Finerenone in diabetic kidney disease: a new frontier for slowing disease progression. Front Med. 2025;12:1580645. https:\/\/doi.org\/10.3389\/fmed.2025.1580645.","journal-title":"Front Med"},{"issue":"9","key":"4672_CR49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1139\/cjpp-2025-0038","volume":"103","author":"IS Alhomoud","year":"2025","unstructured":"Alhomoud IS, Wheeler S, Dixon D. Repurposing incretin therapies: a narrative review of emerging indications across cardiometabolic, liver, kidney, neurological, psychiatric, and other systems. Can J Physiol Pharmacol. 2025;103(9):298\u2013311. https:\/\/doi.org\/10.1139\/cjpp-2025-0038.","journal-title":"Can J Physiol Pharmacol"},{"key":"4672_CR50","doi-asserted-by":"publisher","first-page":"1630160","DOI":"10.3389\/fmed.2025.1630160","volume":"12","author":"MA Alsalloum","year":"2025","unstructured":"Alsalloum MA, Albekery MA, Alhomoud IS. Management of hypertension in chronic kidney disease: current perspectives and therapeutic strategies. Front Med. 2025;12:1630160. https:\/\/doi.org\/10.3389\/fmed.2025.1630160.","journal-title":"Front Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04672-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:03:51Z","timestamp":1767837831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04672-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4672"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04672-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}